Below is a recap of research funding opportunitiesthat were recently announced, nationwide. While these alerts are intended to provide you with a broad-reaching overview of the opportunities available, we certainly want to hear if thereare specific opportunities that you would like to pursue. Please let your Content Director know if you have any questions or are interested in learning more.
OurGrant Alerts dashboard profiles relevant previously announced national-level funding opportunities, which can be sorted by type, agency/funder, and date. Also, your dedicated Content Director and Relationship Director are ready to help with custom research solutions to the challenges you are facing.
Quick Links to Opportunities
These links will take you directly to the websites of the grant opportunities.
The NIH Director’s Transformative Research Award supports individual scientists or groups of scientists proposing bold, groundbreaking, exceptionally innovative, original, and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. There are also three companion RFPs with similar due dates; the Pioneer Award (DP1), New Innovator Award (DP2), and Early Independence Award (DP5).
NIMH seeks applications to evaluate the preliminary effectiveness of therapeutic and service delivery interventions that utilize lethal means safety strategies to reduce suicide risk in healthcare and community settings. Behavioral health clinics that incorporate lethal means counseling into their programming have been associated with significant reductions in suicide attempts and death. Yet, the field is lacking strong evidence on the effectiveness of these strategies tested in healthcare and community settings. Pilot effectiveness research will advance knowledge regarding optimization strategies, therapeutic change mechanisms, and inform decisions about whether further effectiveness testing is warranted.
These center grants will provide funding for leadership, training, research, and outreach activities that will increase and disseminate scientific knowledge in areas supported by the NIA's Division of Aging Biology.
This program aims to encourage investigators to pursue first-in-human or early stage clinical studies for recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. This NOFO is part of a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs are due 60 days before standard NIH dates through January 2027.
This program encourages multidisciplinary investigators to develop exploratory, highly novel new approaches, or innovative applications of existing approaches, to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment. The overarching goal is to extend our understanding of brain development and aging, including studies of the neurodevelopmental origins of later health and disease, by improving repeated measures across longer epochs of the lifespan to better predict outcomes at later ages.
IRGs are awarded to institutions as block grants, providing seed money for newly independent investigators to initiate cancer research projects. The intent is to support these junior faculty in initiating cancer research projects so they can obtain preliminary results that will enable them to compete successfully for national research grants. IRGs can fund up to three one-year pilot grants at $40,000 each. IRGs may propose to budget the annual costs ($120,000) to fewer than three one-year pilot grants if they choose to do so.
PCF seeks high-risk, currently unfunded projects from academic institutions around the world. Grants will be awarded to teams of at least three investigators from nonprofit academic research centers and will support large-scale research projects concerning metastatic, lethal prostate cancer. Grants of up to $1 million per team over a duration of two years will be awarded.
Genentech specifically seeks proposals that address inequities in patient outcomes and healthcare workforce experiences across at least one of the following therapeutic areas: neuroscience and brain health, including but not limited to multiple sclerosis; oncology; ophthalmology; cardiovascular and metabolic disease, including but not limited to diabetes, hypertension, and obesity.
The fund invites applications for its Climate Change and Human Health Seed Grants program, which aims to stimulate the growth of new connections between thinkers working in largely disconnected fields who could together redirect the course of climate change’s impact on human health. Small, early-stage grants of between $2,500 and $50,000 will be awarded through the program.
Eligibility:
There are no eligibility restrictions.
Dates:
Proposals are due by April 25, 2024.
Questions?
We'll be happy to help you find the right grants opportunity for your organization.
About Hanover Research: Founded in 2003, Hanover Research is a global research and grant development firm. The Hanover Grants practice provides research development, grant writing, and strategic advising support to a wide range of institutions and organizations. Our professionals deliver customized proposal review, revision, and production support, while also helping to align strategic priorities to funding trends and opportunities at all levels. To learn more about Hanover Research, visit www.hanoverresearch.com.
Hanover Research 4401 Wilson Blvd, 4th Floor Arlington VA 22203
You received this email because you are subscribed to Grant Alerts and Calendars from Hanover Research.
Update your email preferences to choose the types of emails you receive.
